Cellnovo has filed for 510(k) approval for marketing clearance of the company's diabetes management system.

Cellnovo’s device system comprises an insulin pump patch and mobile touchscreen controller with a built-in blood-glucose meter.

This device regulates insulin injections and has automatic transmission of data to a secured server, which also allows the patient’s condition to be continually monitored by family members and healthcare professionals in real time. — Cynthia Jessup